nach oben

Medical Oncology

Erschienen in:

01.03.2011 | Letter to the Editor

Acute promyelocytic leukemia in a young patient with breast cancer

verfasst von: Ozgur Kara, Evren Ozdemir, Cagatay Arslan, Erkan Dogan, Kadri Altundag

Erschienen in: Medical Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …

Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.CrossRef

Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood. 1995;8(6):3542–52.

Bhatia P, Das R, Ahluwalia J, et al. Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India. Indian J Pathol Microbiol. 2009;52:167–70.PubMedCrossRef

Pedersen-Bjergaard J, Philip P. Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet. 1991;55:119–24.PubMedCrossRef

Smith RE. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project Experience. Clin Breast Cancer. 2003;4:273–9.PubMedCrossRef

Smith SM, Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43–52.PubMedCrossRef

Pagano L, Pulsoni A, Mele L, et al. Acute myeloid leukaemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group. Ann Oncol. 2001;12:203–7.PubMedCrossRef

Lee KD, Chen SC, Chan CH, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev. 2008;17:2647–55.PubMedCrossRef

Hall MJ, Li L, Wiernik PH, et al. BRCA2 mutation and the risk of hematologic malignancy. Leuk Lymphoma. 2006;47:765–7.PubMed

10.

Moskowitz C, Dutcher JP, Wiernik PH. Association of thyroid disease with acute leukemia. Am J Hematol. 1992;39:102–7.PubMedCrossRef

Titel: Acute promyelocytic leukemia in a young patient with breast cancer
verfasst von: Ozgur Kara
Evren Ozdemir
Cagatay Arslan
Erkan Dogan
Kadri Altundag
Publikationsdatum: 01.03.2011
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-010-9437-z

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Acute promyelocytic leukemia in a young patient with breast cancer

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma

Primary adult soft tissue sarcomas: analysis of 294 patients

Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro

Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells

Education, economic status and other risk factors in gastric cancer: “a case–control study of Turkish oncology group”

Primary malignant fibrous histiocytoma of spleen with spontaneous rupture: a case report and literature review

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie